NCT00314171View on ClinicalTrials.gov

A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

437

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Open-angle GlaucomaOcular Hypertension
Interventions
DRUG

Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension

One drop in the study eye(s) twice daily for 12 months

DRUG

Dorzolamide 20 mg/ml + Timolol 5 mg/ml eye drops, solution (COSOPT)

One drop in the study eye(s) twice daily for 12 months

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY